Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.
Culture of pancreatic islets reduces their immunogenicity and results in prolonged graft survival after allotransplantation. The mechanism by which immunogenicity is reduced by culture is not known, but it has been suggested that prolonged graft survival is the result of the depletion of Ia+ cells from the graft. We studied the effect of eliminating Ia+ cells from islets before allotransplantation. Freshly isolated islets were incubated with anti-Ia serum plus complement or with monoclonal antibody to IAk plus complement or were left untreated before transplantation beneath the renal capsule of diabetic recipients. Incubation with anti-Ia serum plus complement eliminated intra-islet IA+ cells as demonstrated by indirect immunofluorescence staining. Incubation with monoclonal antibody to IAk plus complement significantly reduced but did not eliminate IA+ cells. Neither pretreatment regimen influenced survival of islet allografts placed beneath the renal capsule. However, untreated islets injected into the portal circulation were rejected in a low percentage of cases. We conclude that decreased immunogenicity observed after culture is not due solely to the depletion of Ia+ cells and that the site of engraftment has an important impact on graft survival.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D006085:Graft Survival; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D007106:Immune Sera; D016381:Islets of Langerhans Transplantation; D051379:Mice; D008815:Mice, Inbred Strains; D014184:Transplantation, Homologous / Q000379:methods
D000911:Antibodies, Monoclonal; D000949:Histocompatibility Antigens Class II; D007106:Immune Sera; D003165:Complement System Proteins